<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Non‐antiepileptic drugs for trigeminal neuralgia - Zhang, J - 2013 | Cochrane Library</title> <meta content="Non‐antiepileptic drugs for trigeminal neuralgia - Zhang, J - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004029.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Non‐antiepileptic drugs for trigeminal neuralgia - Zhang, J - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004029.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004029.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Non‐antiepileptic drugs for trigeminal neuralgia" name="citation_title"/> <meta content="Jingjing Zhang" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="Mi Yang" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="Muke Zhou" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="Li He" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="heli2003new@126.com" name="citation_author_email"/> <meta content="Ning Chen" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="Joanna M Zakrzewska" name="citation_author"/> <meta content="Eastman Dental Institute" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD004029.pub4" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/12/03" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004029.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004029.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004029.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Amitriptyline [therapeutic use]; Analgesics [*therapeutic use]; Anticonvulsants [*therapeutic use]; Baclofen [therapeutic use]; Carbamazepine [therapeutic use]; Clomipramine [therapeutic use]; Clonidine [analogs &amp; derivatives, therapeutic use]; Pimozide [therapeutic use]; Propoxycaine [therapeutic use]; Randomized Controlled Trials as Topic; Tocainide [therapeutic use]; Trigeminal Neuralgia [*drug therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004029.pub4&amp;doi=10.1002/14651858.CD004029.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="Oy81c7tH";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004029\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004029\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004029\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004029\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004029.pub4",title:"Non\\u2010antiepileptic drugs for trigeminal neuralgia",firstPublishedDate:"Dec 3, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neuromuscular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Oy81c7tH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004029.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004029.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004029.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004029.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004029.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004029.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004029.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004029.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004029.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004029.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3633 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004029.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/full#CD004029-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/full#CD004029-sec-0061"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/full#CD004029-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/full#CD004029-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/full#CD004029-sec-0017"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/full#CD004029-sec-0018"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/full#CD004029-sec-0038"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/full#CD004029-sec-0060"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/appendices#CD004029-sec-0066"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004029.pub4/media/CDSR/CD004029/table_n/CD004029StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/media/CDSR/CD004029/table_n/CD004029StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Non‐antiepileptic drugs for trigeminal neuralgia</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/information#CD004029-cr-0002">Jingjing Zhang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/information#CD004029-cr-0003">Mi Yang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/information#CD004029-cr-0004">Muke Zhou</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/information#CD004029-cr-0005"><i class="icon corresponding-author fa fa-envelope"></i>Li He</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/information#CD004029-cr-0006">Ning Chen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004029.pub4/information#CD004029-cr-0007">Joanna M Zakrzewska</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/information/en#CD004029-sec-0077">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 03 December 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004029.pub4">https://doi.org/10.1002/14651858.CD004029.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004029-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004029-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004029-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004029-abs-0005">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004029-abs-0001" lang="en"> <section id="CD004029-sec-0001"> <h3 class="title" id="CD004029-sec-0001">Background</h3> <p>Trigeminal neuralgia was defined by the International Association for the Study of Pain as a sudden, usually unilateral, severe, brief, stabbing recurrent pain in the distribution of one or more branches of the fifth cranial nerve. Standard treatment is with anti‐epileptic drugs. Non‐antiepileptic drugs have been used in the management of trigeminal neuralgia since the 1970s. This is an update of a review first published in 2006 and previously updated in 2011. </p> </section> <section id="CD004029-sec-0002"> <h3 class="title" id="CD004029-sec-0002">Objectives</h3> <p>To systematically review the efficacy and tolerability of non‐antiepileptic drugs for trigeminal neuralgia. </p> </section> <section id="CD004029-sec-0003"> <h3 class="title" id="CD004029-sec-0003">Search methods</h3> <p>On 20 May 2013, for this updated review, we searched the Cochrane Neuromuscular Disease Group Specialized Register, CENTRAL (2013, Issue 4), MEDLINE (January 1966 to May 2013), EMBASE (January 1980 to May 2013), LILACS (January 1982 to May 2013) and the Chinese Biomedical Retrieval System (1978 to May 2013). We searched clinical trials registries for ongoing trials. </p> </section> <section id="CD004029-sec-0004"> <h3 class="title" id="CD004029-sec-0004">Selection criteria</h3> <p>We included double‐blind, randomised controlled trials in which the active drug was used either alone or in combination with other non‐antiepileptic drugs for at least two weeks. </p> </section> <section id="CD004029-sec-0005"> <h3 class="title" id="CD004029-sec-0005">Data collection and analysis</h3> <p>Two authors decided which trials fitted the inclusion criteria and independently graded risk of bias. We assessed the quality of the evidence according to the GRADE criteria for this update. </p> </section> <section id="CD004029-sec-0006"> <h3 class="title" id="CD004029-sec-0006">Main results</h3> <p>In this 2013 update, we updated the searches, but identified only two new ongoing studies. The review includes four trials involving 139 participants. The primary outcome measure in each was pain relief. Three trials compared one of the oral non‐antiepileptic drugs tizanidine, tocainide or pimozide with carbamazepine. The quality of evidence for all outcomes for which data were available was low. In a trial of tizanidine involving 12 participants (one dropped out due to unrelated disease), one of five participants treated with tizanidine and four of six treated with carbamazepine improved (risk ratio (RR) 0.30, 95% confidence interval (CI) 0.05 to 1.89). Few side effects were noted with tizanidine. For pimozide, there was evidence of greater efficacy than carbamazepine at six weeks. Up to 83% of participants reported adverse effects but these did not lead to withdrawal; the report did not provide comparable data for carbamazepine. Limited data meant that we could not assess the effects of tocainide; however, data from non‐randomised studies (not included in this review) indicate that serious haematological adverse events can occur. A trial involving 47 participants compared 0.5% proparacaine hydrochloride eyedrops with placebo but did not show any significant benefits, again according to low‐quality evidence. The report did not mention adverse events. The proparacaine trial was at low risk of bias; the other trials were at unclear risk of bias overall. </p> </section> <section id="CD004029-sec-0007"> <h3 class="title" id="CD004029-sec-0007">Authors' conclusions</h3> <p>There is low‐quality evidence that the effect of tizanidine is not significantly different than that of carbamazepine in treating trigeminal neuralgia. Pimozide is more effective than carbamazepine, although the evidence is of low quality and the data did not allow comparison of adverse event rates. There is also low‐quality evidence that 0.5% proparacaine hydrochloride eye drops have no benefit over placebo. Limitations in the data for tocainide prevent any conclusions being drawn. There is insufficient evidence from randomised controlled trials to show significant benefit from non‐antiepileptic drugs in trigeminal neuralgia. More research is needed. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004029-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004029-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004029-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004029-abs-0006">فارسی</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004029-abs-0003" lang="en"> <h3>Drugs other than those used for epilepsy for treating trigeminal neuralgia</h3> <p><b>Review question</b> </p> <p>The purpose of this review was to assess the effects of non‐antiepileptic drugs in trigeminal neuralgia. </p> <p><b>Background</b> </p> <p>Trigeminal neuralgia is a condition that affects the trigeminal nerve, the nerve which provides sensation in the skin of the face. The condition causes a sudden, severe, stabbing facial pain near the nose, lips, cheek, eye or ear. The incidence of trigeminal neuralgia is three to five new cases per 100,000 people each year. Standard treatment is with drugs that are used to treat epilepsy (antiepileptic drugs) but non‐antiepileptic drugs, such as baclofen and tocainide, have been used to treat trigeminal neuralgia since the 1970s. </p> <p><b>Study characteristics</b> </p> <p>After a wide search for studies, we identified four trials involving 139 participants in total that met our criteria for inclusion in the review. Three randomised controlled trials compared the three different non‐antiepileptic drugs tizanidine, tocainide and pimozide with carbamazepine, which is the standard drug treatment. No new trials were identified for the update of this review in 2013. </p> <p><b>Results and quality of the evidence</b> </p> <p>Tizanidine did not produce significantly more benefit than carbamazepine according to low‐quality evidence. The reporting of the tocainide trial did not allow us to assess whether the drug helped the pain of trigeminal neuralgia, but studies that were not part of this review suggest that this treatment can have serious harmful effects on the blood. Side effects of pimozide were very common but there was low‐quality evidence that it was more effective than carbamazepine. In a fourth trial there was low‐quality evidence that proparacaine hydrochloride eye drops did not show any significant benefit. </p> <p>There is insufficient evidence from randomised controlled trials to show significant benefit from non‐antiepileptic drugs in trigeminal neuralgia. Further well‐designed randomised controlled trials are needed to establish whether non‐antiepileptic drugs are beneficial in trigeminal neuralgia. </p> <p>The searches for the review are up to date to May 2013.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004029-sec-0061" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004029-sec-0061"></div> <h3 class="title" id="CD004029-sec-0062">Implications for practice</h3> <section id="CD004029-sec-0062"> <p>There is low‐quality evidence that the effect of tizanidine is not significantly different than that of carbamazepine in treating trigeminal neuralgia. Pimozide is more effective than carbamazepine, although the evidence is low‐quality and the data did not allow comparison of adverse event rates. There is also low‐quality evidence that 0.5% proparacaine hydrochloride eye drops have no benefit over placebo. Limitations in the data for tocainide prevent any conclusions being drawn. </p> </section> <h3 class="title" id="CD004029-sec-0063">Implications for research</h3> <section id="CD004029-sec-0063"> <p>More research is needed to determine whether non‐antiepileptic drugs are beneficial in trigeminal neuralgia. Future trials should describe their methods adequately and use clear inclusion criteria, allocation concealment, randomisation, double‐blind assessment, intention‐to‐treat analysis and long‐term follow‐up. The length of washout period before interventions, and between periods in cross‐over trials, must be adequate. Outcome measures should include the frequency, duration and severity of attacks of pain, and quality of life. Adverse events and the number of and explanation for dropouts must be reported. Trials should be adequately powered. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD004029-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD004029-sec-0015"></div> <div class="table" id="CD004029-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Tizanidine versus carbamazepine for trigeminal neuralgia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Tizanidine versus carbamazepine for trigeminal neuralgia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> patients with trigeminal neuralgia<br/> <b>Settings:</b> unclear, Norway<br/> <b>Intervention:</b> tizanidine versus carbamazepine </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Carbamazepine</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Tizanidine </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Immediate improvement in pain relief</b> </p> <p>Number of participants improved (good/very good efficacy) on a self assessed categorical 'overall efficacy score' (0 = no efficacy to 4 = very good)<br/> Follow‐up: 21 days (end of treatment) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>667 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>200 per 1000</b> <br/> (33 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.3</b> <br/> (0.05 to 1.89) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>50% pain reduction 12 weeks after the start of treatment</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only trial of this intervention was of short (21 days) duration</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life assessment 12 weeks after the start of treatment</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only trial of this intervention was of short (21 days) duration</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> (not reported) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse event data collected but no details provided. "Tizanidine was generally better tolerated than carbamazepine, and few side effects were noted"<sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Quality of the evidence downgraded for imprecision. This trial had relatively few patients and thus the measure of effect has wide CIs.<br/> <sup>2</sup>Further downgrading for risk of bias and potential indirectness. Three participants taking tizanidine discontinued taking the optimal dose: two because of lack of efficacy, one due to unrelated disease. Other potential risks of bias were from unclear randomisation, allocation concealment and blinding procedures. Investigators used a non‐validated outcome scale. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004029-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Tocainide versus carbamazepine for trigeminal neuralgia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Tocainide versus carbamazepine for trigeminal neuralgia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> patients with trigeminal neuralgia<br/> <b>Settings:</b> unclear, Sweden<br/> <b>Intervention:</b> tocainide versus carbamazepine </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Carbamazepine</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Tocainide</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain relief (frequency and intensity) from the baseline</b> <br/> 0 to 10‐point scale<br/> Follow‐up: mean 2 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A carry‐over effect may exist and the report does not provide data from the first phase, so we are unable to analyse data for this outcome<sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>50% pain reduction 12 weeks after the start of treatment</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only trial of this intervention was of short (2 weeks) duration</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life assessment 12 weeks after the start of treatment</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only trial of this intervention was of short (2 weeks) duration</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 participants reported adverse effects of tocainide<sup>3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Four participants in this trial could not tolerate being off the drug and so they had no baseline score.<br/> <sup>2</sup>This is a cross‐over study and it may have carry‐over effects.<br/> <sup>3</sup>Tocainide produced nausea, distal paraesthesias and skin rash in three participants, but the report provides no information about adverse effects of carbamazepine. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004029-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Proparacaine hydrochloride 0.5% eye drops versus placebo for trigeminal neuralgia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Proparacaine hydrochloride 0.5% eye drops versus placebo for trigeminal neuralgia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> patients with trigeminal neuralgia<br/> <b>Settings:</b> inpatients, the United States<br/> <b>Intervention:</b> proparacaine hydrochloride 0.5% versus placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Proparacaine hydrochloride 0.5% </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Immediate improvement in pain relief</b> </p> <p>Number of participants improved (≥ 2 level decrease in pain on 10‐point verbal rating scale, or pain gone or rare)<br/> <br/> Follow‐up: 30 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>227 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>241 per 1000</b> <br/> (84 to 680) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.06</b> <br/> (0.37 to 2.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>50% pain reduction 12 weeks after the start of treatment</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only trial of this intervention was of short (30 days) duration</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life assessment 12 weeks after the start of treatment</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only trial of this intervention was of short (30 days) duration</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> (not reported) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Two participants in the control group required medication.<br/> <sup>2</sup>This trial had relatively few patients and thus the RR has wide CIs. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004029-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Pimozide versus carbamazepine for trigeminal neuralgia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Pimozide versus carbamazepine for trigeminal neuralgia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> patients with trigeminal neuralgia<br/> <b>Settings:</b> outpatients, Venezuela<br/> <b>Intervention:</b> pimozide versus carbamazepine </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Carbamazepine</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Pimozide</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain relief (TN score)</b> </p> <p>Follow‐up: 8 weeks (outcome measured at 6 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean improvement in pain at 6 weeks in the carbamazepine group was<br/> 49.7% </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean improvement in TN score at 6 weeks in the pimozide group was<br/> <b>28.7% greater</b> (20.88% to 36.52% greater) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No definition is given for 'improvement' in this paper and we have not therefore presented the number of participants improved </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>50% pain reduction 12 weeks after the start of treatment</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cross‐over study, each phase 8 weeks</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life assessment 12 weeks after the start of treatment</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cross‐over study, each phase 8 weeks</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> <br/> The number of participants with adverse effects<br/> Follow‐up: 24 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Study report does not provide the number of participants with adverse events for carbamazepine</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>This is a cross‐over study and it may have carry‐over effects. Results are from first period only. Risk of selective reporting bias present: first period TN score available at six weeks, when improvement greatest, but not at end of treatment (eight weeks) (other than in graphical format). Second period TN scores available in graphical format only. Insufficient information to assess selection bias and fully analyse blinding.<br/> <sup>2</sup>No baseline characteristics provided. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004029-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004029-sec-0016"></div> <p>Trigeminal neuralgia was defined by the International Association for the Study of Pain as a sudden, usually unilateral, severe, brief, stabbing recurrent pain in the distribution of one or more branches of the fifth cranial nerve (<a href="./references#CD004029-bbs2-0046" title="MerskeyH , BogdukN . Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. 2nd Edition. Seattle: IASP Press, 1994:59‐71. [0931092051] ">Merskey 1994</a>). The International Headache Society (<a href="./references#CD004029-bbs2-0030" title="International Headache Society Classification Subcommittee. International Classification of Headache Disorders. Cephalalgia2004;24 Suppl 1:1‐160. ">Anonymous 2004</a>) set the following criteria for trigeminal neuralgia. </p> <p>A. Paroxysmal attacks of pain lasting from a fraction of a second to two minutes, affecting one or more divisions of the trigeminal nerve and fulfilling criteria B and C.<br/> B. Pain that has at least one of the following characteristics: </p> <p> <ol id="CD004029-list-0001"> <li> <p>intense, sharp, superficial or stabbing;</p> </li> <li> <p>precipitated from trigger areas or by trigger factors.</p> </li> </ol> </p> <p>C. Attacks are stereotyped in the individual patient.<br/> D. There is no clinically evident neurological deficit.<br/> E. Not attributed to another disorder.<br/> <br/> The diagnosis of trigeminal neuralgia is based on clinical findings and there have not been any case controlled studies to validate diagnostic methods. A careful clinical history and examination can distinguish between trigeminal neuralgia and other disorders that cause facial pain (<a href="./references#CD004029-bbs2-0066" title="ZakrzewskaJM . Diagnosis and differential diagnosis of trigeminal neuralgia. Clinical Journal of Pain2002;18(1):14‐21. [PUBMED: 11803298 ] ">Zakrzewska 2002a</a>). </p> <p>Trigeminal neuralgia has an annual incidence of three to five per 100,000 people. It is more common in women than men (age‐adjusted ratio: 1.74:1) and is most widespread in people aged 50 to 69 years. Attacks are commonly on the right side (<a href="./references#CD004029-bbs2-0042" title="KatusicS , BeardCM , BergstralhE , KurlandLT . Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945‐1984. Annals of Neurology1990;27(1):89‐95. [PUBMED: 2301931] ">Katusic 1990</a>; <a href="./references#CD004029-bbs2-0064" title="YoshimasuF , KurlandLT , ElvebackLR . Tic douloureux in Rochester, Minnesota, 1945‐1969. Neurology1972;22(9):952‐6. [PUBMED: 4673380] ">Yoshimasu 1972</a>). More recent data from primary care practices suggest that the incidence may be around 12.7 per 100,000 (<a href="./references#CD004029-bbs2-0043" title="KoopmanJS , DielemanJP , HuygenFJ , deMosM , MartinCG , SturkenboomMC . Incidence of facial pain in the general population. Pain2009;147(1‐3):122‐7. [PUBMED: 19783099] ">Koopman 2009</a>). </p> <p>The aetiology is not clear. Compression of the trigeminal nerve root, at or near the dorsal root entry zone, by a blood vessel is a major causative or contributing factor (<a href="./references#CD004029-bbs2-0034" title="DevorM , AmirR , RappaportZH . Pathophysiology of trigeminal neuralgia: the ignition hypothesis. Clinical Journal of Pain2002;18(1):4‐13. [PUBMED: 11803297] ">Devor 2002</a>). Compression is not always found and it is then necessary to look for other causes. In a few cases trigeminal neuralgia is due to multiple sclerosis. Other rare causes include infiltration of the nerve root, trigeminal ganglion or nerve by a tumour or amyloid, and small infarcts or angiomas in the pons or medulla (<a href="./references#CD004029-bbs2-0032" title="ChengTM , CascinoTL , OnofrioBM . Comprehensive study of diagnosis and treatment of trigeminal neuralgia secondary to tumors. Neurology1993;43(11):2298‐302. [PUBMED: 8232946] ">Cheng 1993</a>). Once all of these possibilities have been excluded, there remain a small proportion of patients in whom the aetiology is undetermined (<a href="./references#CD004029-bbs2-0048" title="NurmikkoTJ , EldridgePR . Trigeminal neuralgia ‐ pathophysiology, diagnosis and current treatment. British Journal of Anaesthesia2001;87(1):117‐32. [PUBMED: 11460800 ] ">Nurmikko 2001</a>). Obermann has shown that atypical type trigeminal neuralgia may be the result of central changes (<a href="./references#CD004029-bbs2-0049" title="ObermannM , YoonMS , EseD , MaschkeM , KaubeH , DienerHC , et al. Impaired trigeminal nociceptive processing in patients with trigeminal neuralgia. Neurology2007;69(9):835‐41. [PUBMED: 17724285 ] ">Obermann 2007</a>). The pain of idiopathic trigeminal neuralgia is indistinguishable from that caused by a demonstrable structural lesion other than vascular compression. </p> <p>Spontaneous remission of trigeminal neuralgia is common but the disorder is often progressive. Remission may last for months or even years but as the attacks become more frequent, the patient may develop persistent pain between episodes. Attacks may come in clusters and can completely disrupt activities of daily living if left untreated (<a href="./references#CD004029-bbs2-0042" title="KatusicS , BeardCM , BergstralhE , KurlandLT . Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945‐1984. Annals of Neurology1990;27(1):89‐95. [PUBMED: 2301931] ">Katusic 1990</a>; <a href="./references#CD004029-bbs2-0067" title="ZakrzewskaJM , PatsalosPN . Long‐term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia. Pain2002;95(3):259‐66. [PUBMED: 11839425] ">Zakrzewska 2002b</a>). </p> <p>Antiepileptic drugs have been used in pain management since the 1960s. The clinical impression is that they are useful for neuropathic pain, especially when the pain is lancinating or burning (<a href="./references#CD004029-bbs2-0041" title="JacoxA , CarrDB , PayneR . Management of cancer pain. US Department of Health and Human Services, Public Health Service. Clinical Practice Guideline1994. ">Jacox 1994</a>). Based on two placebo‐controlled studies of carbamazepine in trigeminal neuralgia, a Cochrane systematic review deduced a number needed to treat to benefit of 1.9 (95% confidence interval (CI) 1.4 to 2.8) (<a href="./references#CD004029-bbs2-0063" title="WiffenPJ , DerryS , MooreRA , McQuayHJ . Carbamazepine for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2011, Issue 1. [DOI: 10.1002/14651858.CD005451.pub2] ">Wiffen 2011</a>). In one randomised controlled trial (RCT), lamotrigine was effective as an add‐on therapy (<a href="./references#CD004029-bbs2-0065" title="ZakrzewskaJM , ChaudhryZ , NurmikkoTJ , PattonDW , MullensEL . Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double‐blind placebo controlled crossover trial. Pain1997;73(2):223‐30. [PUBMED: 9415509] ">Zakrzewska 1997</a>). Little evidence supports a beneficial role of other antiepileptic drugs such as clonazepam, phenytoin and sodium valproate (<a href="./references#CD004029-bbs2-0057" title="SindrupSH , JensenTS . Pharmacotherapy of trigeminal neuralgia. Clinical Journal of Pain2002;18(1):22‐7. [PUBMED: 11803299] ">Sindrup 2002</a>). Gabapentin has been evaluated in a small RCT (<a href="./references#CD004029-bbs2-0044" title="LemosL , FloresS , OliveiraP , AlmeidaA . Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone. Clinical Journal of Pain2008;24(1):64‐75. [PUBMED: 18180639 ] ">Lemos 2008</a>) and pregabalin in a cohort study (<a href="./references#CD004029-bbs2-0050" title="ObermannM , YoonMS , SensenK , MaschkeM , DienerHC , KatsaravaZ . Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia2008;28(2):174‐81. [PUBMED: 18039340] ">Obermann 2008</a>). The long‐term effects of carbamazepine have been evaluated in only one study, which showed either loss of effect or poor tolerability in half the participants after 10 years (<a href="./references#CD004029-bbs2-0059" title="TaylorJC , BrauerS , EspirML . Long‐term treatment of trigeminal neuralgia with carbamazepine. Postgraduate Medical Journal1981;57(663):16‐8. [PUBMED: 7279817] ">Taylor 1981</a>). In a long‐term cohort study of oxcarbazepine, pain increased with progression of disease severity and the drug became less effective in long‐term pain control (<a href="./references#CD004029-bbs2-0067" title="ZakrzewskaJM , PatsalosPN . Long‐term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia. Pain2002;95(3):259‐66. [PUBMED: 11839425] ">Zakrzewska 2002b</a>). </p> <p>Non‐antiepileptic drugs have been used to treat trigeminal neuralgia since the 1970s. Conventional analgesics such as aspirin, codeine and non‐steroidal anti‐inflammatory drugs are not used since experience suggests that they are not helpful. There has been a reported RCT on the use of dextromethorphan, an antitussive (cough suppressant) drug with analgesic effects, in patients with mixed facial neuralgias (<a href="./references#CD004029-bbs2-0010" title="GilronI , BooherSL , RowanMS , SmollerMS , MaxMB . A randomized, controlled trial of high‐dose dextromethorphan in facial neuralgias. Neurology2000;55(7):964‐71. [PUBMED: 11061252] ">Gilron 2000</a>). Other drugs that are used include baclofen, pimozide, racemic ketamine, proparacaine, tocainide, misoprostol and capsaicin. Baclofen is a gamma‐aminobutyric acid receptor agonist that has the least serious adverse effects (<a href="./references#CD004029-bbs2-0058" title="SteardoL , LeoA , MaranoE . Efficacy of baclofen in trigeminal neuralgia and some other painful conditions. A clinical trial. European Neurology1984;23(1):51‐5. [PUBMED: 6201366 ] ">Steardo 1984</a>). Pimozide is a neuroleptic that has shown significant relief of pain when compared with carbamazepine in a double‐blind, cross‐over trial. Racemic ketamine is an anaesthetic which showed some benefit when treating acute pain but was ineffective for pain lasting more than five years (<a href="./references#CD004029-bbs2-0045" title="MathisenLC , SkjelbredP , SkoglundLA , OyeI . Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain. Pain1995;61(2):215‐20. [PUBMED: 7659431] ">Mathisen 1995</a>). Topical ophthalmic anaesthetics, such as proparacaine, have been reported to relieve trigeminal neuralgia pain in some patients but not in a randomised trial (<a href="./references#CD004029-bbs2-0001" title="KondziolkaD , LemleyT , KestleJR , LunsfordLD , FrommGH , JannettaPJ . The effect of single‐application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double‐blind placebo‐controlled trial. Journal of Neurosurgery1994;80(6):993‐7. [PUBMED: 8189280] ">Kondziolka 1994</a>). Tocainide is a drug used to prevent cardiac arrhythmias. It has been withdrawn from the market because of bone marrow suppression (<a href="./references#CD004029-bbs2-0051" title="RawsonNS , HardingSR , MalcolmE , LueckL . Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use. Journal of Clinical Epidemiology1998;51(12):1343‐55. [PUBMED: 10086829] ">Rawson 1998</a>) but was tried in trigeminal neuralgia. Misoprostol is a long‐acting prostaglandin E1 analogue which, in an open‐label study, relieved trigeminal neuralgia in six of seven participants with definite multiple sclerosis who had failed to respond to conventional pharmacologic therapy (<a href="./references#CD004029-bbs2-0052" title="RederAT , ArnasonBG . Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue. Neurology1995;45(6):1097‐100. [PUBMED: 7783870] ">Reder 1995</a>). Use of capsaicin, the pungent component of red pepper, has been reported in two case studies (<a href="./references#CD004029-bbs2-0036" title="FuscoBM , AlessandriM . Analgesic effect of capsaicin in idiopathic trigeminal neuralgia. Anesthesia and Analgesia1992;74(3):375‐7. [PUBMED: 1539818] ">Fusco 1992</a>). There have been previous systematic reviews of all drugs for trigeminal neuralgia (<a href="./references#CD004029-bbs2-0056" title="SindrupSH , JensenTS . Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain1999;83(3):389‐400. [PUBMED: 10568846] ">Sindrup 1999</a>; <a href="./references#CD004029-bbs2-0068" title="ZakrzewskaJM , LinskeyM . Trigeminal neuralgia. Clinical Evidence. http://clinicalevidence.bmj.com/ceweb/conditions/nud/1207/1207.jsp 2009 (accessed April 2010). ">Zakrzewska 2009</a>). The review in Clinical Evidence (<a href="./references#CD004029-bbs2-0068" title="ZakrzewskaJM , LinskeyM . Trigeminal neuralgia. Clinical Evidence. http://clinicalevidence.bmj.com/ceweb/conditions/nud/1207/1207.jsp 2009 (accessed April 2010). ">Zakrzewska 2009</a>) is updated every 18 months. International guidelines which used systematic review methodology have also been published (<a href="./references#CD004029-bbs2-0033" title="CruccuG , GronsethG , AlksneJ , ArgoffC , BraininM , BurchielK , et al. AAN‐EFNS guidelines on trigeminal neuralgia management. European Journal of Neurology2008;15(10):1013‐28. [PUBMED: 18721143] ">Cruccu 2008</a>; <a href="./references#CD004029-bbs2-0038" title="GronsethG , CruccuG , AlksneJ , ArgoffC , BraininM , BurchielK , et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence‐based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology2008;71(15):1183‐90. [PUBMED: 18716236] ">Gronseth 2008</a>). The aim of this review is to systematically review all double‐blind RCTs of non‐antiepileptic drugs for trigeminal neuralgia. Antiepileptic drugs for trigeminal neuralgia have been included in other Cochrane reviews (<a href="./references#CD004029-bbs2-0047" title="MooreRA , StraubeS , WiffenPJ , DerryS , McQuayHJ . Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007076.pub2] ">Moore 2009</a>; <a href="./references#CD004029-bbs2-0061" title="WiffenPJ , ReesJ . Lamotrigine for acute and chronic pain (Cochrane Review). Cochrane Database of Systematic Reviews2007, Issue 2. [DOI: 10.1002/14651858.CD006044.pub2] ">Wiffen 2010a</a>; <a href="./references#CD004029-bbs2-0062" title="WiffenPJ , McQuayHJ , ReesJ , MooreRA . Gabapentin for acute and chronic pain. Cochrane Database of Systematic Reviews2005, Issue 3. [DOI: 10.1002/14651858.CD005452] ">Wiffen 2010b</a>; <a href="./references#CD004029-bbs2-0063" title="WiffenPJ , DerryS , MooreRA , McQuayHJ . Carbamazepine for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2011, Issue 1. [DOI: 10.1002/14651858.CD005451.pub2] ">Wiffen 2011</a>). </p> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004029-sec-0017" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004029-sec-0017"></div> <p>To systematically review the efficacy and tolerability of non‐antiepileptic drugs for trigeminal neuralgia. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004029-sec-0018" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004029-sec-0018"></div> <section id="CD004029-sec-0019"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004029-sec-0020"> <h4 class="title">Types of studies</h4> <p>We searched for all double‐blinded, randomised controlled trials (RCTs) which lasted for at least two weeks and involved non‐antiepileptic drugs in the treatment of trigeminal neuralgia. </p> </section> <section id="CD004029-sec-0021"> <h4 class="title">Types of participants</h4> <p>We included all causes of trigeminal neuralgia, both idiopathic and symptomatic, where the diagnostic criteria were clearly defined. </p> </section> <section id="CD004029-sec-0022"> <h4 class="title">Types of interventions</h4> <p>We included all non‐antiepileptic drugs used to achieve analgesia. Non‐antiepileptic drugs include: baclofen, pimozide, racemic ketamine, proparacaine, dextromethorphan, tocainide or any other single non‐antiepileptic drug in any dose or combination. Comparison interventions were placebo, no treatment or carbamazepine. </p> <p>The hypotheses below were to be tested.</p> <p> <ol id="CD004029-list-0002"> <li> <p>Therapy A* is more effective in controlling trigeminal neuralgia than placebo treatment.</p> </li> <li> <p>Therapy A* is more effective in controlling trigeminal neuralgia than no treatment.</p> </li> <li> <p>Therapy A* is more effective in controlling trigeminal neuralgia than carbamazepine.</p> </li> <li> <p>Therapy B** is more effective in controlling trigeminal neuralgia than placebo treatment.</p> </li> <li> <p>Therapy B** is more effective in controlling trigeminal neuralgia than no treatment.</p> </li> <li> <p>Therapy B** is more effective in controlling trigeminal neuralgia than therapy A.</p> </li> <li> <p>Therapy B** is more effective in controlling trigeminal neuralgia than carbamazepine.</p> </li> </ol> </p> <p>*Therapy A = baclofen, pimozide, racemic ketamine, proparacaine, tocainide or any other single non‐antiepileptic drug.<br/> **Therapy B = combination of any two drugs in therapy A. </p> </section> <section id="CD004029-sec-0023"> <h4 class="title">Types of outcome measures</h4> <section id="CD004029-sec-0024"> <h5 class="title">Primary outcomes</h5> <p>The primary outcome was immediate improvement in pain relief evaluated as decreased pain intensity or trigeminal neuralgia score, that is number of attacks per day and their intensity. </p> </section> <section id="CD004029-sec-0025"> <h5 class="title">Secondary outcomes</h5> <p>Secondary outcomes were:</p> <p> <ol id="CD004029-list-0003"> <li> <p>improvement in pain intensity or trigeminal neuralgia score at least 12 weeks after the start of treatment; </p> </li> <li> <p>the number of participants with 50% pain reduction at least 12 weeks after the start of treatment; </p> </li> <li> <p>quality of life measured with a validated scale, such as the Short Form 36 Health Survey questionnaire (SF‐36) (<a href="./references#CD004029-bbs2-0060" title="WareJEJr , SherbourneCD . The MOS 36‐item short‐form health survey (SF‐36). I. Conceptual framework and item selection. Medical Care1992;30(6):473‐83. ">Ware 1992</a>) at least 12 weeks after the start of treatment; and </p> </li> <li> <p>adverse effects that were attributable to treatment by two weeks from the start of treatment. </p> </li> </ol> </p> <section id="CD004029-sec-0026"> <h6 class="title">Outcomes for inclusion in a 'Summary of findings' table</h6> <p>We included a 'Summary of findings' table to illustrate the findings of the review and our assessment of the quality of evidence for key outcomes: </p> <p> <ul id="CD004029-list-0004"> <li> <p>immediate improvement in pain relief;</p> </li> <li> <p>improvement in pain intensity or trigeminal neuralgia score at least 12 weeks after the start of treatment; </p> </li> <li> <p>the number of participants with 50% pain reduction at least 12 weeks after the start of treatment; </p> </li> <li> <p>quality of life measured with a validated scale, such as the Short Form 36 Health Survey questionnaire (SF‐36) (<a href="./references#CD004029-bbs2-0060" title="WareJEJr , SherbourneCD . The MOS 36‐item short‐form health survey (SF‐36). I. Conceptual framework and item selection. Medical Care1992;30(6):473‐83. ">Ware 1992</a>) at least 12 weeks after the start of treatment; and </p> </li> <li> <p>adverse effects.</p> </li> </ul> </p> <p>We graded the quality of the evidence from included RCTs as high, moderate, low or very low based on the GRADE criteria. These start from a grading of high for RCTs and reasons for downgrading are: study limitations, consistency of effect, imprecision, indirectness and publication bias. Also, evidence from downgraded RCTs can be upgraded for a large effect size, when all plausible confounding would tend to underestimate the size of the effect or when there is a dose‐response gradient (<a href="./references#CD004029-bbs2-0037" title="GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328:1490‐4. ">GRADE working group 2004</a>; <a href="./references#CD004029-bbs2-0054" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011a</a>; <a href="./references#CD004029-bbs2-0055" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011b</a>). </p> </section> </section> </section> </section> <section id="CD004029-sec-0027"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD004029-sec-0028"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Neuromuscular Disease Group Specialized Register (20 May 2013), CENTRAL (2013, Issue 4 in <i>The Cochrane Library</i>), MEDLINE (January 1966 to May 2013), EMBASE (January 1980 to May 2013), LILACS (January 1982 to May 2013), the Chinese Biomedical Retrieval System (1978 to May 2013), ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">http://www.clinicaltrials.gov/</a>) (May 2013) and the World Health Organization International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/en/" target="_blank">http://www.who.int/ictrp/en/</a>). There were no restrictions on the basis of language. We reviewed the bibliographies of the randomised trials found and contacted the authors and known experts in the field to identify additional published or unpublished data. For the detailed search strategies see <a href="./appendices#CD004029-sec-0067">Appendix 1</a> (MEDLINE), <a href="./appendices#CD004029-sec-0068">Appendix 2</a> (EMBASE), <a href="./appendices#CD004029-sec-0069">Appendix 3</a> (CENTRAL), <a href="./appendices#CD004029-sec-0070">Appendix 4</a> (LILACS), <a href="./appendices#CD004029-sec-0071">Appendix 5</a> (Chinese Biomedical Retrieval System), <a href="./appendices#CD004029-sec-0072">Appendix 6</a> (ClinicalTrials.gov) and <a href="./appendices#CD004029-sec-0073">Appendix 7</a> (ICTRP). </p> </section> <section id="CD004029-sec-0029"> <h4 class="title">Searching other resources</h4> <p>In this 2013 update, we searched the following 10 journals in electronic database of Chinese Biomedical Retrieval System rather than by handsearching: </p> <p> <ul id="CD004029-list-0005"> <li> <p><i>Chinese Journal of Neurology</i>; </p> </li> <li> <p><i>Chinese Journal of Neuroscience</i>; </p> </li> <li> <p><i>Journal of Apoplexy and Nervous Diseases</i>; </p> </li> <li> <p><i>Journal of Brain and Nervous Diseases</i>; </p> </li> <li> <p><i>Journal of Clinical Neurology</i>; </p> </li> <li> <p><i>Chinese Journal of Nervous and Mental Diseases</i>; </p> </li> <li> <p><i>Chinese Journal of Clinical Neurosciences</i>; </p> </li> <li> <p><i>Chinese Journal of Pain Medicine</i>; </p> </li> <li> <p><i>Chinese Journal of New Drugs and Clinical Remedies</i>; </p> </li> <li> <p><i>Chinese Journal of Neuromedicine</i>. </p> </li> </ul> </p> <p>We also searched the retrieved articles for any other potentially missing studies and a personal reference database collected over 20 years (JZ). </p> </section> </section> <section id="CD004029-sec-0030"> <h3 class="title" id="CD004029-sec-0030">Data collection and analysis</h3> <section id="CD004029-sec-0031"> <h4 class="title">Selection of studies</h4> <p>Two review authors (JZ and NC) scrutinised the titles and abstracts identified from the updated searches. We obtained the full text of any study of possible relevance for independent assessment. The authors decided which trials fitted the inclusion criteria and graded their risk of bias. The authors resolved disagreements about inclusion by discussion. Two review authors (LH and JZ) arbitrated if there was a failure in resolving disagreement. If necessary and if possible we contacted the trial authors for clarification. </p> </section> <section id="CD004029-sec-0032"> <h4 class="title">Data extraction and management</h4> <p>We collected information from each study about diagnostic criteria, comparability of groups at baseline, pain condition and number of patients studied, non‐antiepileptic drug type and dose regimen, study design, study duration and follow‐up, length of washout, analgesic outcome measures and results, withdrawals and adverse effects (minor and major). </p> <p>Two review authors (JZ and MY) independently extracted and checked data on participants, methods, interventions, outcomes and results using a data extraction form. We obtained missing data from the authors whenever possible. One author (MY) entered data into the Cochrane software Review Manager, currently RevMan 5.2 (<a href="./references#CD004029-bbs2-0053" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). A second author (MZ) checked the data entry and a third author (JZ) did another independent assessment. </p> </section> <section id="CD004029-sec-0033"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed the risk of bias of each trial. The assessment took into account the security of randomisation, allocation concealment, blinding of participants and personnel and blinding of outcome assessors, completeness of outcome data, selective reporting and any other potential bias, as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004029-bbs2-0040" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S(editors). Cochrane Handbook for Systematic Reviews of Intervention Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). Two review authors assessed these items independently and subdivided trials. </p> </section> <section id="CD004029-sec-0034"> <h4 class="title">Measures of treatment effect</h4> <p>We calculated a treatment effect with the Cochrane statistical package RevMan. We expressed results as risk ratios (RRs) or risk differences (RDs) with 95% confidence intervals (CIs) for dichotomous outcomes and mean differences (MDs) with 95% CIs for continuous outcomes. According to the method of assessing risk of bias in cross‐over trials (<a href="./references#CD004029-bbs2-0040" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S(editors). Cochrane Handbook for Systematic Reviews of Intervention Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>), we evaluated the following items for cross‐over trials: (i) whether the cross‐over design was suitable; (ii) whether there was a carry‐over effect; (iii) whether the first period data were available; (iv) incorrect analysis; and (v) comparability of results with those from parallel‐group trials. We planned to analyse all outcomes under consideration. </p> </section> <section id="CD004029-sec-0035"> <h4 class="title">Dealing with missing data</h4> <p>We analysed data on an intention‐to‐treat basis. Therefore, we included all participants with available data in the analysis in the group to which they were allocated, regardless of whether or not they received the allocated intervention. If in the original reports participants were not analysed in the group to which they were randomised, and there was sufficient information in the trial report, we attempted to restore them to the correct group. We obtained missing data from the study authors whenever possible. </p> </section> <section id="CD004029-sec-0036"> <h4 class="title">Assessment of reporting biases</h4> <p>As there were insufficient studies, we did not use a funnel plot to investigate the possibility of publication bias but used a descriptive analysis to evaluate the possible reporting bias. </p> </section> <section id="CD004029-sec-0037"> <h4 class="title">Data synthesis</h4> <p>As the non‐antiepileptic and control group interventions tested in the included studies were different, we did not use RevMan to perform meta‐analyses of the studies. Instead, we described the results of each trial as reported by the authors. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004029-sec-0038" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004029-sec-0038"></div> <section id="CD004029-sec-0039"> <h3 class="title">Description of studies</h3> <section id="CD004029-sec-0040"> <h4 class="title">Results of the search</h4> <p>In this 2013 update, we performed electronic searches and retrieved 71 references from the Cochrane Neuromuscular Disease Group Specialized Register, 185 from CENTRAL, 1571 from MEDLINE, 314 from EMBASE, 17 from LILACS, 156 from the Chinese Biomedical Retrieval System, 54 from Clinicaltrials.gov and 24 from WHO ICTRP. We have identified two new ongoing studies since the original review in 2005. In total 29 reports potentially met our inclusion criteria. </p> <p>We included four trials with 139 participants (<a href="./references#CD004029-bbs2-0001" title="KondziolkaD , LemleyT , KestleJR , LunsfordLD , FrommGH , JannettaPJ . The effect of single‐application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double‐blind placebo‐controlled trial. Journal of Neurosurgery1994;80(6):993‐7. [PUBMED: 8189280] ">Kondziolka 1994</a>; <a href="./references#CD004029-bbs2-0002" title="LechinF , van derDijsB , LechinME , AmatJ , LechinAE , CabreraA , et al. Pimozide therapy for trigeminal neuralgia. Archives of Neurology1989;46(9):960‐3. [PUBMED: 2673161] ">Lechin 1989</a>; <a href="./references#CD004029-bbs2-0003" title="LindströmP , LindblomU . The analgesic effect of tocainide in trigeminal neuralgia. Pain1987;28(1):45‐50. [PUBMED: 3103044] ">Lindström 1987</a>; <a href="./references#CD004029-bbs2-0004" title="VilmingST , LybergT , LatasteX . Tizanidine in the management of trigeminal neuralgia. Cephalalgia1986;6(3):181‐2. [PUBMED: 3533272] ">Vilming 1986</a>) (see <a href="./references#CD004029-sec-0083" title="">Characteristics of included studies</a>). We excluded 23 studies and there were two ongoing studies. </p> </section> <section id="CD004029-sec-0041"> <h4 class="title">Included studies</h4> <p>The review includes four trials. Three studies compared an oral non‐antiepileptic drug with carbamazepine; the drugs used were tizanidine (<a href="./references#CD004029-bbs2-0004" title="VilmingST , LybergT , LatasteX . Tizanidine in the management of trigeminal neuralgia. Cephalalgia1986;6(3):181‐2. [PUBMED: 3533272] ">Vilming 1986</a>), tocainide (<a href="./references#CD004029-bbs2-0003" title="LindströmP , LindblomU . The analgesic effect of tocainide in trigeminal neuralgia. Pain1987;28(1):45‐50. [PUBMED: 3103044] ">Lindström 1987</a>), and pimozide (<a href="./references#CD004029-bbs2-0002" title="LechinF , van derDijsB , LechinME , AmatJ , LechinAE , CabreraA , et al. Pimozide therapy for trigeminal neuralgia. Archives of Neurology1989;46(9):960‐3. [PUBMED: 2673161] ">Lechin 1989</a>). The duration of treatments was generally short: two weeks (<a href="./references#CD004029-bbs2-0003" title="LindströmP , LindblomU . The analgesic effect of tocainide in trigeminal neuralgia. Pain1987;28(1):45‐50. [PUBMED: 3103044] ">Lindström 1987</a>), 21 days (<a href="./references#CD004029-bbs2-0004" title="VilmingST , LybergT , LatasteX . Tizanidine in the management of trigeminal neuralgia. Cephalalgia1986;6(3):181‐2. [PUBMED: 3533272] ">Vilming 1986</a>) and eight weeks per treatment period in <a href="./references#CD004029-bbs2-0002" title="LechinF , van derDijsB , LechinME , AmatJ , LechinAE , CabreraA , et al. Pimozide therapy for trigeminal neuralgia. Archives of Neurology1989;46(9):960‐3. [PUBMED: 2673161] ">Lechin 1989</a>. The trials took place in Norway (<a href="./references#CD004029-bbs2-0004" title="VilmingST , LybergT , LatasteX . Tizanidine in the management of trigeminal neuralgia. Cephalalgia1986;6(3):181‐2. [PUBMED: 3533272] ">Vilming 1986</a>), Sweden (<a href="./references#CD004029-bbs2-0003" title="LindströmP , LindblomU . The analgesic effect of tocainide in trigeminal neuralgia. Pain1987;28(1):45‐50. [PUBMED: 3103044] ">Lindström 1987</a>), and Venezuela (<a href="./references#CD004029-bbs2-0002" title="LechinF , van derDijsB , LechinME , AmatJ , LechinAE , CabreraA , et al. Pimozide therapy for trigeminal neuralgia. Archives of Neurology1989;46(9):960‐3. [PUBMED: 2673161] ">Lechin 1989</a>). </p> <p>The fourth study, <a href="./references#CD004029-bbs2-0001" title="KondziolkaD , LemleyT , KestleJR , LunsfordLD , FrommGH , JannettaPJ . The effect of single‐application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double‐blind placebo‐controlled trial. Journal of Neurosurgery1994;80(6):993‐7. [PUBMED: 8189280] ">Kondziolka 1994</a> (47 participants), was conducted in the US and compared a single application of 0.5% proparacaine hydrochloride eye drops with buffered saline placebo. </p> <p>Two studies had a parallel‐group design (<a href="./references#CD004029-bbs2-0001" title="KondziolkaD , LemleyT , KestleJR , LunsfordLD , FrommGH , JannettaPJ . The effect of single‐application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double‐blind placebo‐controlled trial. Journal of Neurosurgery1994;80(6):993‐7. [PUBMED: 8189280] ">Kondziolka 1994</a>; <a href="./references#CD004029-bbs2-0004" title="VilmingST , LybergT , LatasteX . Tizanidine in the management of trigeminal neuralgia. Cephalalgia1986;6(3):181‐2. [PUBMED: 3533272] ">Vilming 1986</a>), the other two were cross‐over trials. </p> <p>Outcome measures in <a href="http://archie.cochrane.org/sections/documents/view?version=z1311221606058039953245296465672%26format=REVMAN#STD-Vilming-1986" target="_blank">Vilming 1986</a> (12 participants) were VAS pain and overall efficacy of medication (no efficacy, slight, moderate, good, very good) daily. <a href="http://archie.cochrane.org/sections/documents/view?version=z1311221606058039953245296465672%26format=REVMAN#STD-Lindstr_x00f6_m-1987" target="_blank">Lindström 1987</a> (12 participants) used a zero to 10‐point scale to measure the frequency and severity (duration and intensity) of attacks; <a href="http://archie.cochrane.org/sections/documents/view?version=z1311221606058039953245296465672%26format=REVMAN#STD-Lechin-1989" target="_blank">Lechin 1989</a> (68 participants) used a TN symptom score (1 to 100); and <a href="http://archie.cochrane.org/sections/documents/view?version=z1311221606058039953245296465672%26format=REVMAN#STD-Kondziolka-1994" target="_blank">Kondziolka 1994</a> reported a zero to 10‐point verbal pain rating scale and a descriptive scale (unchanged, moderately better, markedly better, or worse) to grade outcome. </p> <p>None of the study reports stated the investigators' conflicts of interest and only <a href="./references#CD004029-bbs2-0003" title="LindströmP , LindblomU . The analgesic effect of tocainide in trigeminal neuralgia. Pain1987;28(1):45‐50. [PUBMED: 3103044] ">Lindström 1987</a> and <a href="./references#CD004029-bbs2-0002" title="LechinF , van derDijsB , LechinME , AmatJ , LechinAE , CabreraA , et al. Pimozide therapy for trigeminal neuralgia. Archives of Neurology1989;46(9):960‐3. [PUBMED: 2673161] ">Lechin 1989</a> provided information on funding, which came from an institute or foundation. </p> </section> <section id="CD004029-sec-0042"> <h4 class="title">Excluded studies</h4> <p>We excluded 23 studies (<a href="./references#CD004029-bbs2-0005" title="CarassoRL , YehudaS , StreiflerM . Clomipramine and amitriptyline in the treatment of severe pain. International Journal of Neuroscience1979;9(3):191‐4. [PUBMED: 489262] ">Carasso 1979</a>; <a href="./references#CD004029-bbs2-0006" title="FrommGH , TerrenceCF , ChatthaAS . Baclofen in the treatment of trigeminal neuralgia: double‐blind study and long‐term follow‐up. Annals of Neurology1984;15(3):240‐4. [PUBMED: 6372646] ">Fromm 1984</a>; <a href="./references#CD004029-bbs2-0007" title="FrommGH , TerrenceCF . Comparison of L‐baclofen and racemic baclofen in trigeminal neuralgia. Neurology1987;37(11):1725‐8. [PUBMED: 3313099] ">Fromm 1987</a>; <a href="./references#CD004029-bbs2-0008" title="FrommGH , AumentadoD , TerrenceCF . A clinical and experimental investigation of the effects of tizanidine in trigeminal neuralgia. Pain1993;53(3):265‐71. [PUBMED: 8351156] ">Fromm 1993</a>; <a href="./references#CD004029-bbs2-0009" title="GazeraniP , PedersenNS , StaahlC , DrewesAM , Arendt‐NielsenL . Subcutaneous botulinum toxin type A reduces capsaicin‐induced trigeminal pain and vasomotor reactions in human skin. Pain2009;141(1‐2):60‐9. [PUBMED: 19004549] ">Gazerani 2009</a>; <a href="./references#CD004029-bbs2-0010" title="GilronI , BooherSL , RowanMS , SmollerMS , MaxMB . A randomized, controlled trial of high‐dose dextromethorphan in facial neuralgias. Neurology2000;55(7):964‐71. [PUBMED: 11061252] ">Gilron 2000</a>; <a href="./references#CD004029-bbs2-0011" title="JiangL , NiuG . Therapeutic effect observation of neurotropin in the treatment of senile essential trigeminal neuralgia. Chinese Journal of Practical Nervous Diseases2007;10(7):25‐6. ">Jiang 2007</a>; <a href="./references#CD004029-bbs2-0012" title="JiangL , NiuG . The effect of neurotropin on idiopathic trigeminal neuralgia. Zhejiang Medical Journal2008;30(6):644‐5. ">Jiang 2008</a>; <a href="./references#CD004029-bbs2-0013" title="KanaiA , SaitoM , HokaS . Subcutaneous sumatriptan for refractory trigeminal neuralgia. Headache2006;46(4):577‐82. [PUBMED: 16643550] ">Kanai 2006a</a>; <a href="./references#CD004029-bbs2-0014" title="KanaiA , SuzukiA , OsawaS , HokaS . Sumatriptan alleviates pain in patients with trigeminal neuralgia. Clinical Journal of Pain2006;22(8):677‐80. [PUBMED: 16988562] ">Kanai 2006b</a>; <a href="./references#CD004029-bbs2-0015" title="KanaiA , SuzukiA , KobayashiM , HokaS . Intranasal lidocaine 8% spray for second‐division trigeminal neuralgia. British Journal of Anaesthesia2006;97:559‐63. [PUBMED: 16882684] ">Kanai 2006c</a>; <a href="./references#CD004029-bbs2-0016" title="LemosL , FloresS , OliveiraP , AlmeidaA . Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone. Clinical Journal of Pain2008;24(1):64‐75. [PUBMED: 18180639] ">Laurinda 2008</a>; <a href="./references#CD004029-bbs2-0017" title="LiuY , DengX . Effect analysis of low dosage meticorten in trigeminal neuralgia. Journal of North Sichuan Medical College1999;14(2):84‐5. ">Liu 1999</a>; <a href="./references#CD004029-bbs2-0018" title="LuoX , ChenM , GuoK , ZhangM , LiZ . Control study of the effect of tiapride together with doxa in trigeminal neuralgia. Journal of Brain and Nervous Disease1995;3(1):58. ">Luo 1995</a>; <a href="./references#CD004029-bbs2-0019" title="ParekhS , ShahK , KotdawallaH , GandhiI . Baclofen in carbamazepine resistant trigeminal neuralgia ‐ A double blind clinical trial. Cephalalgia1989;9 Suppl 10:392‐3. [EMBASE: 1990167097] ">Parekh 1989</a>; <a href="./references#CD004029-bbs2-0020" title="ShaoJ , XiangF , YingJ , WangH . The clinical observation of tramadol and doxa in trigeminal neuralgia. Journal of Yunyang Medical College1999;18(2):106‐7. ">Shao 1999</a>; <a href="./references#CD004029-bbs2-0021" title="ShaoYQ . Methycobal in trigeminal neuralgia [弥可保治疗三叉神经痛50例疗效观察]. Asia‐Pacific Traditional Medicine2011;7:63‐4. ">Shao 2011</a>; <a href="./references#CD004029-bbs2-0022" title="SilverM , BlumD , GraingerJ , HammerAE , QuessyS . Double‐blind, placebo‐controlled trial of lamotrigine in combination with other medications for neuropathic pain. Journal of Pain and Symptom Management2007;34(4):446‐54. [PUBMED: 17662571] ">Silver 2007</a>; <a href="./references#CD004029-bbs2-0023" title="StajcicZ , JuniperRP , TodorovicL . Peripheral streptomycin/lidocaine injections versus lidocaine alone in the treatment of idiopathic trigeminal neuralgia. A double blind controlled trial. Journal of Cranio‐Maxillo‐Facial Surgery1990;18(6):243‐6. [PUBMED: 2212020] ">Stajcic 1990</a>; <a href="./references#CD004029-bbs2-0024" title="WangX , LiW . Shenjingzhitongsan for trigeminal neuralgia [Shenjingzhitongsan zhi liao san cha shen jing tong 128 li]. Henan Traditional Chinese Medicine2007;27(4):35. ">Wang 2007</a>; <a href="./references#CD004029-bbs2-0025" title="XuZ . The analgesic effect of mexiletine in idiopathic trigeminal neuralgia. Central Plains Medical Journal1998;25(3):33. ">Xu 1998</a>; <a href="./references#CD004029-bbs2-0026" title="YanHM . Clinical observation of botulinum toxin type A in trigeminal neuralgia [A型肉毒毒素治疗三叉神经痛64例临床观察]. Jilin Medical Journal2011;32:6821‐2. ">Yan 2011</a>; <a href="./references#CD004029-bbs2-0027" title="ZhaoY . The efficacy of carbamazepine combined with doxepin treatment of primary trigeminal neuralgia [卡马西平联用多虑平治疗原发性三叉神经痛疗效观察]. Guide of China Medicine2011;9:36‐7. ">Zhao 2011</a>) as: they were not RCTs (<a href="./references#CD004029-bbs2-0014" title="KanaiA , SuzukiA , OsawaS , HokaS . Sumatriptan alleviates pain in patients with trigeminal neuralgia. Clinical Journal of Pain2006;22(8):677‐80. [PUBMED: 16988562] ">Kanai 2006b</a>; <a href="./references#CD004029-bbs2-0017" title="LiuY , DengX . Effect analysis of low dosage meticorten in trigeminal neuralgia. Journal of North Sichuan Medical College1999;14(2):84‐5. ">Liu 1999</a>; <a href="./references#CD004029-bbs2-0018" title="LuoX , ChenM , GuoK , ZhangM , LiZ . Control study of the effect of tiapride together with doxa in trigeminal neuralgia. Journal of Brain and Nervous Disease1995;3(1):58. ">Luo 1995</a>; <a href="./references#CD004029-bbs2-0025" title="XuZ . The analgesic effect of mexiletine in idiopathic trigeminal neuralgia. Central Plains Medical Journal1998;25(3):33. ">Xu 1998</a>; <a href="./references#CD004029-bbs2-0021" title="ShaoYQ . Methycobal in trigeminal neuralgia [弥可保治疗三叉神经痛50例疗效观察]. Asia‐Pacific Traditional Medicine2011;7:63‐4. ">Shao 2011</a>; <a href="./references#CD004029-bbs2-0026" title="YanHM . Clinical observation of botulinum toxin type A in trigeminal neuralgia [A型肉毒毒素治疗三叉神经痛64例临床观察]. Jilin Medical Journal2011;32:6821‐2. ">Yan 2011</a>; <a href="./references#CD004029-bbs2-0027" title="ZhaoY . The efficacy of carbamazepine combined with doxepin treatment of primary trigeminal neuralgia [卡马西平联用多虑平治疗原发性三叉神经痛疗效观察]. Guide of China Medicine2011;9:36‐7. ">Zhao 2011</a>), not double‐blind (<a href="./references#CD004029-bbs2-0005" title="CarassoRL , YehudaS , StreiflerM . Clomipramine and amitriptyline in the treatment of severe pain. International Journal of Neuroscience1979;9(3):191‐4. [PUBMED: 489262] ">Carasso 1979</a>; <a href="./references#CD004029-bbs2-0024" title="WangX , LiW . Shenjingzhitongsan for trigeminal neuralgia [Shenjingzhitongsan zhi liao san cha shen jing tong 128 li]. Henan Traditional Chinese Medicine2007;27(4):35. ">Wang 2007</a>), were of a combination of treatments rather than a single non‐antiepileptic drug (<a href="./references#CD004029-bbs2-0016" title="LemosL , FloresS , OliveiraP , AlmeidaA . Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone. Clinical Journal of Pain2008;24(1):64‐75. [PUBMED: 18180639] ">Laurinda 2008</a>; <a href="./references#CD004029-bbs2-0020" title="ShaoJ , XiangF , YingJ , WangH . The clinical observation of tramadol and doxa in trigeminal neuralgia. Journal of Yunyang Medical College1999;18(2):106‐7. ">Shao 1999</a>; <a href="./references#CD004029-bbs2-0022" title="SilverM , BlumD , GraingerJ , HammerAE , QuessyS . Double‐blind, placebo‐controlled trial of lamotrigine in combination with other medications for neuropathic pain. Journal of Pain and Symptom Management2007;34(4):446‐54. [PUBMED: 17662571] ">Silver 2007</a>), were repeated (<a href="./references#CD004029-bbs2-0011" title="JiangL , NiuG . Therapeutic effect observation of neurotropin in the treatment of senile essential trigeminal neuralgia. Chinese Journal of Practical Nervous Diseases2007;10(7):25‐6. ">Jiang 2007</a>), the participants enrolled did not correspond with the protocol (<a href="./references#CD004029-bbs2-0012" title="JiangL , NiuG . The effect of neurotropin on idiopathic trigeminal neuralgia. Zhejiang Medical Journal2008;30(6):644‐5. ">Jiang 2008</a>) or their characteristics were not described (<a href="./references#CD004029-bbs2-0010" title="GilronI , BooherSL , RowanMS , SmollerMS , MaxMB . A randomized, controlled trial of high‐dose dextromethorphan in facial neuralgias. Neurology2000;55(7):964‐71. [PUBMED: 11061252] ">Gilron 2000</a>), the duration of treatment was less than two weeks (<a href="./references#CD004029-bbs2-0006" title="FrommGH , TerrenceCF , ChatthaAS . Baclofen in the treatment of trigeminal neuralgia: double‐blind study and long‐term follow‐up. Annals of Neurology1984;15(3):240‐4. [PUBMED: 6372646] ">Fromm 1984</a>; <a href="./references#CD004029-bbs2-0007" title="FrommGH , TerrenceCF . Comparison of L‐baclofen and racemic baclofen in trigeminal neuralgia. Neurology1987;37(11):1725‐8. [PUBMED: 3313099] ">Fromm 1987</a>; <a href="./references#CD004029-bbs2-0008" title="FrommGH , AumentadoD , TerrenceCF . A clinical and experimental investigation of the effects of tizanidine in trigeminal neuralgia. Pain1993;53(3):265‐71. [PUBMED: 8351156] ">Fromm 1993</a>; <a href="./references#CD004029-bbs2-0019" title="ParekhS , ShahK , KotdawallaH , GandhiI . Baclofen in carbamazepine resistant trigeminal neuralgia ‐ A double blind clinical trial. Cephalalgia1989;9 Suppl 10:392‐3. [EMBASE: 1990167097] ">Parekh 1989</a>), loss to follow‐up was more than 20% (<a href="./references#CD004029-bbs2-0023" title="StajcicZ , JuniperRP , TodorovicL . Peripheral streptomycin/lidocaine injections versus lidocaine alone in the treatment of idiopathic trigeminal neuralgia. A double blind controlled trial. Journal of Cranio‐Maxillo‐Facial Surgery1990;18(6):243‐6. [PUBMED: 2212020] ">Stajcic 1990</a>) or the study objective did not correspond to the protocol (<a href="./references#CD004029-bbs2-0013" title="KanaiA , SaitoM , HokaS . Subcutaneous sumatriptan for refractory trigeminal neuralgia. Headache2006;46(4):577‐82. [PUBMED: 16643550] ">Kanai 2006a</a>; <a href="./references#CD004029-bbs2-0015" title="KanaiA , SuzukiA , KobayashiM , HokaS . Intranasal lidocaine 8% spray for second‐division trigeminal neuralgia. British Journal of Anaesthesia2006;97:559‐63. [PUBMED: 16882684] ">Kanai 2006c</a>). (See <a href="./references#CD004029-sec-0084" title="">Characteristics of excluded studies</a>). </p> </section> </section> <section id="CD004029-sec-0043"> <h3 class="title">Risk of bias in included studies</h3> <p>The 'Risk of bias' summary (<a href="#CD004029-fig-0001">Figure 1</a>) shows the review authors' judgements about each 'Risk of bias' item for the included studies. One study had an overall low risk of bias (<a href="./references#CD004029-bbs2-0001" title="KondziolkaD , LemleyT , KestleJR , LunsfordLD , FrommGH , JannettaPJ . The effect of single‐application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double‐blind placebo‐controlled trial. Journal of Neurosurgery1994;80(6):993‐7. [PUBMED: 8189280] ">Kondziolka 1994</a>). For the other three the risk of bias was generally unclear and in particular there was not enough information to assess the adequacy of randomisation and blinding. </p> <div class="figure" id="CD004029-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each methodological quality item for each included study. Red = high risk of bias; yellow = unclear risk of bias; green = low risk of bias" data-id="CD004029-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004029.pub4/media/CDSR/CD004029/image_n/nCD004029-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each methodological quality item for each included study. Red = high risk of bias; yellow = unclear risk of bias; green = low risk of bias </p> </div> </div> </div> <section id="CD004029-sec-0044"> <h4 class="title">Allocation</h4> <p>Four trials (<a href="./references#CD004029-bbs2-0001" title="KondziolkaD , LemleyT , KestleJR , LunsfordLD , FrommGH , JannettaPJ . The effect of single‐application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double‐blind placebo‐controlled trial. Journal of Neurosurgery1994;80(6):993‐7. [PUBMED: 8189280] ">Kondziolka 1994</a>; <a href="./references#CD004029-bbs2-0002" title="LechinF , van derDijsB , LechinME , AmatJ , LechinAE , CabreraA , et al. Pimozide therapy for trigeminal neuralgia. Archives of Neurology1989;46(9):960‐3. [PUBMED: 2673161] ">Lechin 1989</a>; <a href="./references#CD004029-bbs2-0003" title="LindströmP , LindblomU . The analgesic effect of tocainide in trigeminal neuralgia. Pain1987;28(1):45‐50. [PUBMED: 3103044] ">Lindström 1987</a>; <a href="./references#CD004029-bbs2-0004" title="VilmingST , LybergT , LatasteX . Tizanidine in the management of trigeminal neuralgia. Cephalalgia1986;6(3):181‐2. [PUBMED: 3533272] ">Vilming 1986</a>) stated that they were randomised. Only one trial (<a href="./references#CD004029-bbs2-0001" title="KondziolkaD , LemleyT , KestleJR , LunsfordLD , FrommGH , JannettaPJ . The effect of single‐application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double‐blind placebo‐controlled trial. Journal of Neurosurgery1994;80(6):993‐7. [PUBMED: 8189280] ">Kondziolka 1994</a>) described an adequate method of randomisation; the participants were randomly assigned by the tossing of a coin. This trial also compared the characteristics of the two groups, which showed that the randomisation had been effective. The report states that "The code was not broken until the study was completed". The other three trials did not describe their method of 'random allocation' or allocation concealment. </p> </section> <section id="CD004029-sec-0045"> <h4 class="title">Blinding</h4> <p>Most trial reports described the method of blinding only in broad terms such as 'double‐blind', which made it impossible to know exactly who was blinded (<a href="./references#CD004029-bbs2-0040" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S(editors). Cochrane Handbook for Systematic Reviews of Intervention Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). All four trials (<a href="./references#CD004029-bbs2-0001" title="KondziolkaD , LemleyT , KestleJR , LunsfordLD , FrommGH , JannettaPJ . The effect of single‐application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double‐blind placebo‐controlled trial. Journal of Neurosurgery1994;80(6):993‐7. [PUBMED: 8189280] ">Kondziolka 1994</a>; <a href="./references#CD004029-bbs2-0002" title="LechinF , van derDijsB , LechinME , AmatJ , LechinAE , CabreraA , et al. Pimozide therapy for trigeminal neuralgia. Archives of Neurology1989;46(9):960‐3. [PUBMED: 2673161] ">Lechin 1989</a>; <a href="./references#CD004029-bbs2-0003" title="LindströmP , LindblomU . The analgesic effect of tocainide in trigeminal neuralgia. Pain1987;28(1):45‐50. [PUBMED: 3103044] ">Lindström 1987</a>; <a href="./references#CD004029-bbs2-0004" title="VilmingST , LybergT , LatasteX . Tizanidine in the management of trigeminal neuralgia. Cephalalgia1986;6(3):181‐2. [PUBMED: 3533272] ">Vilming 1986</a>) claimed that they were double‐blind; one trial (<a href="./references#CD004029-bbs2-0001" title="KondziolkaD , LemleyT , KestleJR , LunsfordLD , FrommGH , JannettaPJ . The effect of single‐application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double‐blind placebo‐controlled trial. Journal of Neurosurgery1994;80(6):993‐7. [PUBMED: 8189280] ">Kondziolka 1994</a>) described this in detail. <a href="./references#CD004029-bbs2-0002" title="LechinF , van derDijsB , LechinME , AmatJ , LechinAE , CabreraA , et al. Pimozide therapy for trigeminal neuralgia. Archives of Neurology1989;46(9):960‐3. [PUBMED: 2673161] ">Lechin 1989</a> stated that trial and placebo medications were identical. </p> </section> <section id="CD004029-sec-0046"> <h4 class="title">Incomplete outcome data</h4> <p>Two trials reported that there were dropouts or withdrawals (<a href="./references#CD004029-bbs2-0002" title="LechinF , van derDijsB , LechinME , AmatJ , LechinAE , CabreraA , et al. Pimozide therapy for trigeminal neuralgia. Archives of Neurology1989;46(9):960‐3. [PUBMED: 2673161] ">Lechin 1989</a>; <a href="./references#CD004029-bbs2-0004" title="VilmingST , LybergT , LatasteX . Tizanidine in the management of trigeminal neuralgia. Cephalalgia1986;6(3):181‐2. [PUBMED: 3533272] ">Vilming 1986</a>) and they reported the reason but did not use intention‐to‐treat analysis to analyse the results. </p> </section> <section id="CD004029-sec-0047"> <h4 class="title">Selective reporting</h4> <p>We considered the risk of selective reporting bias introduced by the trial investigators to be high in two trials (<a href="./references#CD004029-bbs2-0002" title="LechinF , van derDijsB , LechinME , AmatJ , LechinAE , CabreraA , et al. Pimozide therapy for trigeminal neuralgia. Archives of Neurology1989;46(9):960‐3. [PUBMED: 2673161] ">Lechin 1989</a>; <a href="./references#CD004029-bbs2-0004" title="VilmingST , LybergT , LatasteX . Tizanidine in the management of trigeminal neuralgia. Cephalalgia1986;6(3):181‐2. [PUBMED: 3533272] ">Vilming 1986</a>). In <a href="./references#CD004029-bbs2-0004" title="VilmingST , LybergT , LatasteX . Tizanidine in the management of trigeminal neuralgia. Cephalalgia1986;6(3):181‐2. [PUBMED: 3533272] ">Vilming 1986</a>, the trial authors did not report visual analogue scale (VAS) measurements, one of the prespecified outcomes, in a suitable way. <a href="./references#CD004029-bbs2-0002" title="LechinF , van derDijsB , LechinME , AmatJ , LechinAE , CabreraA , et al. Pimozide therapy for trigeminal neuralgia. Archives of Neurology1989;46(9):960‐3. [PUBMED: 2673161] ">Lechin 1989</a> reported data primarily in graphs. The first period data for reduction in trigeminal neuralgia score were reported in the text after six weeks of treatment, which the trial authors describe as the point of "maximal improvement" for both pimozide and carbamazepine. This outcome is therefore at high risk of bias owing to selective reporting. We considered the risk of reporting bias in <a href="./references#CD004029-bbs2-0003" title="LindströmP , LindblomU . The analgesic effect of tocainide in trigeminal neuralgia. Pain1987;28(1):45‐50. [PUBMED: 3103044] ">Lindström 1987</a> and <a href="./references#CD004029-bbs2-0001" title="KondziolkaD , LemleyT , KestleJR , LunsfordLD , FrommGH , JannettaPJ . The effect of single‐application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double‐blind placebo‐controlled trial. Journal of Neurosurgery1994;80(6):993‐7. [PUBMED: 8189280] ">Kondziolka 1994</a> to be low. </p> </section> <section id="CD004029-sec-0048"> <h4 class="title">Other potential sources of bias</h4> <p>Only one trial (<a href="./references#CD004029-bbs2-0001" title="KondziolkaD , LemleyT , KestleJR , LunsfordLD , FrommGH , JannettaPJ . The effect of single‐application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double‐blind placebo‐controlled trial. Journal of Neurosurgery1994;80(6):993‐7. [PUBMED: 8189280] ">Kondziolka 1994</a>) claimed that the treatment groups were the same with regard to gender, age, duration of disease and pain scores. The others did not compare the baseline characteristics of the groups in detail. Many of the trials lacked clear diagnostic criteria and referred to typical trigeminal neuralgia but did not define it and they did not report whether participants had idiopathic trigeminal neuralgia. One cross‐over trial (<a href="./references#CD004029-bbs2-0003" title="LindströmP , LindblomU . The analgesic effect of tocainide in trigeminal neuralgia. Pain1987;28(1):45‐50. [PUBMED: 3103044] ">Lindström 1987</a>) did not report a washout period, so there is a high risk of a carry‐over effect in this study. <a href="./references#CD004029-bbs2-0004" title="VilmingST , LybergT , LatasteX . Tizanidine in the management of trigeminal neuralgia. Cephalalgia1986;6(3):181‐2. [PUBMED: 3533272] ">Vilming 1986</a> did not report whether there was a washout period prior to the start of the trial. </p> </section> </section> <section id="CD004029-sec-0049"> <h3 class="title" id="CD004029-sec-0049">Effects of interventions</h3> <p>See: <a href="./full#CD004029-tbl-0001"><b>Summary of findings for the main comparison</b> Tizanidine versus carbamazepine for trigeminal neuralgia</a>; <a href="./full#CD004029-tbl-0002"><b>Summary of findings 2</b> Tocainide versus carbamazepine for trigeminal neuralgia</a>; <a href="./full#CD004029-tbl-0003"><b>Summary of findings 3</b> Proparacaine hydrochloride 0.5% eye drops versus placebo for trigeminal neuralgia</a>; <a href="./full#CD004029-tbl-0004"><b>Summary of findings 4</b> Pimozide versus carbamazepine for trigeminal neuralgia</a> </p> <p>As the non‐antiepileptic and control group interventions tested in the included studies were different, we did not combine the results. Instead, we describe the results of each trial as reported by the authors. </p> <p>Three trials reported the proportion of participants with a good initial effect evaluated by pain intensity or trigeminal neuralgia scores two weeks after treatment. </p> <section id="CD004029-sec-0050"> <h4 class="title">Tizanidine versus carbamazepine</h4> <p>This comparison was reported in <a href="./references#CD004029-bbs2-0004" title="VilmingST , LybergT , LatasteX . Tizanidine in the management of trigeminal neuralgia. Cephalalgia1986;6(3):181‐2. [PUBMED: 3533272] ">Vilming 1986</a>, a very small parallel‐group trial (12 participants, with six in each group). </p> <p>The duration of treatment was 21 days. Three participants taking tizanidine discontinued taking the optimal dose, one because of unrelated disease and two as a result of intolerable pain. The report provides results for 11 participants. </p> <section id="CD004029-sec-0051"> <h5 class="title">Primary outcome: immediate improvement in pain relief</h5> <p>A visual analogue scale (VAS) was used to evaluate pain but the report does not include the results. The investigators reported overall efficacy assessed by participants and investigators on a four‐point scale (no efficacy, slight, moderate, good or very good) but provide no other details of the measure. At the end of treatment, one of five participants improved with tizanidine and four of six with carbamazepine (RR 0.30, 95% CI 0.05 to 1.89) (<a href="./references#CD004029-fig-0002" title="">Analysis 1.1</a>). The difference was not statistically significant. </p> </section> <section id="CD004029-sec-0052"> <h5 class="title">Secondary outcomes</h5> <p>The duration of treatment was 21 days, which was too short for the measurement of our secondary efficacy outcomes at 12 weeks. </p> <p>Side effects were not specifically reported, other than, "Tizanidine was generally better tolerated than carbamazepine, and few side effects were noted. Laboratory tests did not show any deviations that could be related to the test medication." </p> </section> </section> <section id="CD004029-sec-0053"> <h4 class="title">Tocainide versus carbamazepine</h4> <p>One double‐blind, cross‐over RCT (<a href="./references#CD004029-bbs2-0003" title="LindströmP , LindblomU . The analgesic effect of tocainide in trigeminal neuralgia. Pain1987;28(1):45‐50. [PUBMED: 3103044] ">Lindström 1987</a>) in 12 participants compared tocainide with carbamazepine. </p> <p>The duration of each phase was two weeks. However, the authors did not report the washout period or data from the end of the first arm in this trial. Since there is a high risk of carry‐over effects, we have not reported the quantitative data from this trial. </p> <p>For adverse effects, the authors reported that tocainide produced nausea, distal paraesthesias and skin rash which led to withdrawal from the study, but non‐randomised studies showed an unacceptable rate of serious haematological side effects and deaths (see <a href="#CD004029-sec-0060">Discussion</a>). The Lindstrom study did not report whether the adverse effects of tocainide were dose‐dependent. </p> </section> <section id="CD004029-sec-0054"> <h4 class="title">Proparacaine hydrochloride 0.5% versus placebo</h4> <p>In a parallel‐group RCT (<a href="./references#CD004029-bbs2-0001" title="KondziolkaD , LemleyT , KestleJR , LunsfordLD , FrommGH , JannettaPJ . The effect of single‐application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double‐blind placebo‐controlled trial. Journal of Neurosurgery1994;80(6):993‐7. [PUBMED: 8189280] ">Kondziolka 1994</a>), investigators assigned 47 participants to receive a single dose of proparacaine hydrochloride 0.5% or placebo eye drops. Each participant was treated only once. </p> <section id="CD004029-sec-0055"> <h5 class="title">Primary outcome: immediate improvement in pain relief</h5> <p>A verbal pain rating scale (VRS) was used to assess the effect. There was no significant reduction of pain after 3, 10 or 30 days. At 30 days, six of 25 participants improved (i.e. had a 2 or more level decrease in pain on 10‐point scale, or pain was gone or rare) with proparacaine hydrochloride 0.5%, and five of 22 improved with placebo (RR 1.06, 95% CI 0.37 to 2.99) (<a href="./references#CD004029-fig-0003" title="">Analysis 2.1</a>). Eleven participants in the treatment group and 14 participants in the control group underwent surgery during follow‐up. Two participants in the control group required medication. </p> </section> <section id="CD004029-sec-0056"> <h5 class="title">Secondary outcomes</h5> <p>The study duration was too short to report secondary efficacy outcomes at 12 weeks. For adverse events, the authors state "We observed no morbidity related to placement of either proparacaine or saline eyedrops." </p> </section> </section> <section id="CD004029-sec-0057"> <h4 class="title">Pimozide versus carbamazepine</h4> <p>One double‐blind, cross‐over RCT (<a href="./references#CD004029-bbs2-0002" title="LechinF , van derDijsB , LechinME , AmatJ , LechinAE , CabreraA , et al. Pimozide therapy for trigeminal neuralgia. Archives of Neurology1989;46(9):960‐3. [PUBMED: 2673161] ">Lechin 1989</a>) compared pimozide and carbamazepine in 68 people but nine were not admitted to the treatment phase. Eleven participants did not contribute data to the statistical analysis: 10 because of protocol deviations and one dropped out. The trial lasted 24 weeks: four weeks of placebo washout, eight weeks of treatment following random assignment to carbamazepine or pimozide, four weeks of abrupt withdrawal with placebo substitution and eight weeks of cross‐over treatment. </p> <section id="CD004029-sec-0058"> <h5 class="title">Primary outcome: immediate improvement in pain relief</h5> <p>A trigeminal neuralgia score ranging from 0 to 100 was used to assess the effect. However, the authors did not state how they defined 'improvement', other than stating that all of the 48 participants on pimozide and 27 out of 48 participants on carbamazepine "showed improvement". They do give a percentage improvement score for each group after six weeks' treatment (when the authors state that there was "maximal improvement"); they also report that "similar differences were obtained" at weeks seven and eight, week eight being the end of the first treatment period. Week seven and eight results are provided in graph form in the study report as are second period results. In the first period, the reduction in total trigeminal neuralgia score was 78.4% with pimozide and 49.7% with carbamazepine, six weeks after starting treatment (MD 28.70%, 95% CI 20.88% to 36.52%) (see <a href="./references#CD004029-fig-0004" title="">Analysis 3.1</a>). </p> </section> <section id="CD004029-sec-0059"> <h5 class="title">Secondary outcomes</h5> <p>The study duration was too short (eight‐week treatment phases) to report secondary efficacy outcomes at 12 weeks. </p> <p>Adverse effects were recorded in 40 (83.3%) participants with pimozide. These were physical and mental retardation, hand tremors, memory impairment, involuntary movements during sleep and slight Parkinson's disease manifestations. In the carbamazepine period, 22 serious adverse effects occurred (one abnormal full blood count, one abnormal liver function, 18 lethargy, one inappropriate secretion of vasopressin and one erythematous exanthem that disappeared after the trial. However, the report does not provide the total number of participants with adverse effects in each group. Since some participants might have had more than one adverse effect with carbamazepine, we could not calculate the incidence of adverse effects between the two drugs. For pimozide, the adverse effects could be attenuated by reducing the dose, so may be dose‐dependent. </p> <p>No studies were alike, therefore we did not perform a meta‐analysis.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004029-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004029-sec-0060"></div> <p>We did not identify any new randomised controlled trials (RCTs) for this update. In a previous update, we re‐evaluated the nine trials in the original review in the light of changed inclusion criteria. Since most drugs used in trigeminal neuralgia need to be escalated slowly in dose, and a steady state reached at the maximum dose, we considered it important that a trial should report the results from at least two weeks at the maximum steady state dose. Trigeminal neuralgia is a chronic condition and drugs need to provide pain relief for long periods. Our inclusion criteria therefore stated that the trial had last at least two weeks using the maximum steady dose. After reassessment of the trials, four clinical trials investigating non‐antiepileptic drugs in the treatment of trigeminal neuralgia, with a total of 139 participants, met the inclusion criteria. The drugs tested were tizanidine, tocainide, proparacaine hydrochloride (0.5% eye drops) and pimozide. We were unable to pool the results because of heterogeneity between the studies. The results of these trials can be summarised as follows. </p> <p> <ol id="CD004029-list-0006"> <li> <p>There was no significant difference in effect between carbamazepine and tizanidine measured using the selected outcomes. Larger and better studies are required to draw any conclusions (<a href="./references#CD004029-bbs2-0004" title="VilmingST , LybergT , LatasteX . Tizanidine in the management of trigeminal neuralgia. Cephalalgia1986;6(3):181‐2. [PUBMED: 3533272] ">Vilming 1986</a>) (<a href="./full#CD004029-tbl-0001">summary of findings Table for the main comparison</a>). </p> </li> <li> <p>The efficacy of tocainide was not analysed because of the high risk of a carry‐over effect and no separate first phase data were presented that would have enabled us to analyse these separately (<a href="./full#CD004029-tbl-0002">summary of findings Table 2</a>). In non‐randomised studies, tocainide produced serious haematological side effects limiting its use (<a href="./references#CD004029-bbs2-0051" title="RawsonNS , HardingSR , MalcolmE , LueckL . Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use. Journal of Clinical Epidemiology1998;51(12):1343‐55. [PUBMED: 10086829] ">Rawson 1998</a>). </p> </li> <li> <p>Proparacaine hydrochloride 0.5% instilled into the eyes was simple and safe but no significant effect was observed when compared with placebo (<a href="./references#CD004029-bbs2-0001" title="KondziolkaD , LemleyT , KestleJR , LunsfordLD , FrommGH , JannettaPJ . The effect of single‐application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double‐blind placebo‐controlled trial. Journal of Neurosurgery1994;80(6):993‐7. [PUBMED: 8189280] ">Kondziolka 1994</a>) (<a href="./full#CD004029-tbl-0003">summary of findings Table 3</a>). In this trial three participants had first division (V1) pain only and a further four had V1 as well as other division involvement. The rest of the participants did not have V1 involvement, therefore they were looking for a systemic effect of the drug. The authors did not report the results separately for the V1 participants but presumably if the drug had worked better in that group they would have reported it. We therefore assume that the trial showed that the drug neither works centrally nor peripherally. </p> </li> <li> <p>The effect of pimozide was evaluated in one double‐blind, cross‐over RCT (<a href="./full#CD004029-tbl-0004">summary of findings Table 4</a>). Adverse effects were common and the authors suggested it should not be chosen as a first‐line treatment option (<a href="./references#CD004029-bbs2-0002" title="LechinF , van derDijsB , LechinME , AmatJ , LechinAE , CabreraA , et al. Pimozide therapy for trigeminal neuralgia. Archives of Neurology1989;46(9):960‐3. [PUBMED: 2673161] ">Lechin 1989</a>). </p> </li> </ol> </p> <p>These conclusions are limited by methodological considerations such as the method of randomisation, quality of double‐blinding, allocation concealment, study duration and selection of outcome measures. All of the included trials were either inadequately reported or had methodological flaws. The quality problems were as follows: </p> <p> <ol id="CD004029-list-0007"> <li> <p>the method of randomisation and allocation concealment, diagnostic criteria and comparability of the baseline groups were not reported; </p> </li> <li> <p>the washout period was not reported in a cross‐over trial;</p> </li> <li> <p>the blinding methods were unclear;</p> </li> <li> <p>dropouts were high and not reported in detail and intention‐to‐treat analysis was not carried out; </p> </li> <li> <p>the follow‐up time was short;</p> </li> <li> <p>the selection of assessment tools was not consistent and adverse effects were not reported in some trials; </p> </li> <li> <p>the participants recruited in some trials were not typical and did not meet the diagnostic criteria for trigeminal neuralgia. </p> </li> </ol> </p> <p>At present we cannot draw any definitive conclusions about the effect and reliability of any non‐antiepileptic drug in trigeminal neuralgia. </p> <p>All these trials were carried out before more rigorous methods were introduced for the conduct of RCTs. No study included a power calculation and the primary and secondary outcome measures were not clearly stated. One of the studies (<a href="./references#CD004029-bbs2-0001" title="KondziolkaD , LemleyT , KestleJR , LunsfordLD , FrommGH , JannettaPJ . The effect of single‐application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double‐blind placebo‐controlled trial. Journal of Neurosurgery1994;80(6):993‐7. [PUBMED: 8189280] ">Kondziolka 1994</a>) had a low risk of bias; the other three had an unclear risk of bias.The Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) has provided some guidelines on the use of outcome measures which need to be considered when designing future trials in this field (<a href="./references#CD004029-bbs2-0035" title="DworkinRH , TurkDC , FarrarJT , HaythornthwaiteJA , JensenMP , KatzNP , et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain2005;113(1‐2):9‐19. [PUBMED: 15621359] ">Dworkin 2005</a>). Trials in patients with trigeminal neuralgia are difficult to conduct due to the lack of knowledge about the natural history of the condition. Patients can go into a natural period of complete pain remission, as is reported to have potentially occurred in one participant in the tizanidine study (<a href="./references#CD004029-bbs2-0004" title="VilmingST , LybergT , LatasteX . Tizanidine in the management of trigeminal neuralgia. Cephalalgia1986;6(3):181‐2. [PUBMED: 3533272] ">Vilming 1986</a>). The following outcomes need to be measured: the frequency of attacks of pain, the duration of each attack and the severity of attack. Evoked or spontaneous pain could also be measured as there is a suggestion that this can be altered differently (<a href="./references#CD004029-bbs2-0031" title="BeydounA , SchmidtD , D'SouzaJ . Oxcarbazepine versus carbamazepine in trigeminal neuralgia: a meta‐analysis of three double blind comparative trials. Neurology2002;58 Suppl 3:831‐2. ">Beydoun 2002</a>). A 50% pain reduction is considered a good outcome in all chronic pain studies of other conditions but a higher target is possible in patients with trigeminal neuralgia. Quality of life assessment is important because patients may be unable to eat or socialise and if rendered pain‐free with drugs they may be unable to walk due to ataxia, diplopia and drowsiness. In the current update of the review we revised our outcomes to include 50% pain reduction and quality of life assessment. </p> <p>The results of our review are consistent with the previous studies described in the <a href="#CD004029-sec-0016">Background</a> section. </p> </section> </section> <div class="figures-list"> <div class="figure" id="CD004029-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/media/CDSR/CD004029/urn:x-wiley:14651858:media:CD004029:CD004029-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/media/CDSR/CD004029/image_t/tCD004029-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each methodological quality item for each included study. Red = high risk of bias; yellow = unclear risk of bias; green = low risk of bias" data-id="CD004029-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004029.pub4/media/CDSR/CD004029/image_n/nCD004029-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each methodological quality item for each included study. Red = high risk of bias; yellow = unclear risk of bias; green = low risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/full#CD004029-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/media/CDSR/CD004029/image_n/nCD004029-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004029-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/media/CDSR/CD004029/urn:x-wiley:14651858:media:CD004029:CD004029-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/media/CDSR/CD004029/image_t/tCD004029-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Tizanidine versus carbamazepine, Outcome 1 Number improved (reported by participant on global efficacy scale)." data-id="CD004029-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004029.pub4/media/CDSR/CD004029/image_n/nCD004029-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Tizanidine versus carbamazepine, Outcome 1 Number improved (reported by participant on global efficacy scale). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/references#CD004029-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/media/CDSR/CD004029/image_n/nCD004029-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004029-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/media/CDSR/CD004029/urn:x-wiley:14651858:media:CD004029:CD004029-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/media/CDSR/CD004029/image_t/tCD004029-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Proparacaine hydrochloride 0.5% versus placebo, Outcome 1 Number improved (reported by participant on verbal pain rating scale)." data-id="CD004029-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004029.pub4/media/CDSR/CD004029/image_n/nCD004029-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Proparacaine hydrochloride 0.5% versus placebo, Outcome 1 Number improved (reported by participant on verbal pain rating scale). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/references#CD004029-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/media/CDSR/CD004029/image_n/nCD004029-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004029-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/media/CDSR/CD004029/urn:x-wiley:14651858:media:CD004029:CD004029-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/media/CDSR/CD004029/image_t/tCD004029-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Pimozide versus carbamazepine, Outcome 1 Improvement (reduction in total TN score)." data-id="CD004029-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004029.pub4/media/CDSR/CD004029/image_n/nCD004029-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Pimozide versus carbamazepine, Outcome 1 Improvement (reduction in total TN score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/references#CD004029-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/media/CDSR/CD004029/image_n/nCD004029-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD004029-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Tizanidine versus carbamazepine for trigeminal neuralgia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Tizanidine versus carbamazepine for trigeminal neuralgia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> patients with trigeminal neuralgia<br/> <b>Settings:</b> unclear, Norway<br/> <b>Intervention:</b> tizanidine versus carbamazepine </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Carbamazepine</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Tizanidine </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Immediate improvement in pain relief</b> </p> <p>Number of participants improved (good/very good efficacy) on a self assessed categorical 'overall efficacy score' (0 = no efficacy to 4 = very good)<br/> Follow‐up: 21 days (end of treatment) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>667 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>200 per 1000</b> <br/> (33 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.3</b> <br/> (0.05 to 1.89) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>50% pain reduction 12 weeks after the start of treatment</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only trial of this intervention was of short (21 days) duration</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life assessment 12 weeks after the start of treatment</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only trial of this intervention was of short (21 days) duration</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> (not reported) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse event data collected but no details provided. "Tizanidine was generally better tolerated than carbamazepine, and few side effects were noted"<sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Quality of the evidence downgraded for imprecision. This trial had relatively few patients and thus the measure of effect has wide CIs.<br/> <sup>2</sup>Further downgrading for risk of bias and potential indirectness. Three participants taking tizanidine discontinued taking the optimal dose: two because of lack of efficacy, one due to unrelated disease. Other potential risks of bias were from unclear randomisation, allocation concealment and blinding procedures. Investigators used a non‐validated outcome scale. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Tizanidine versus carbamazepine for trigeminal neuralgia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/full#CD004029-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004029-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Tocainide versus carbamazepine for trigeminal neuralgia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Tocainide versus carbamazepine for trigeminal neuralgia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> patients with trigeminal neuralgia<br/> <b>Settings:</b> unclear, Sweden<br/> <b>Intervention:</b> tocainide versus carbamazepine </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Carbamazepine</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Tocainide</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain relief (frequency and intensity) from the baseline</b> <br/> 0 to 10‐point scale<br/> Follow‐up: mean 2 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A carry‐over effect may exist and the report does not provide data from the first phase, so we are unable to analyse data for this outcome<sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>50% pain reduction 12 weeks after the start of treatment</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only trial of this intervention was of short (2 weeks) duration</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life assessment 12 weeks after the start of treatment</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only trial of this intervention was of short (2 weeks) duration</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 participants reported adverse effects of tocainide<sup>3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Four participants in this trial could not tolerate being off the drug and so they had no baseline score.<br/> <sup>2</sup>This is a cross‐over study and it may have carry‐over effects.<br/> <sup>3</sup>Tocainide produced nausea, distal paraesthesias and skin rash in three participants, but the report provides no information about adverse effects of carbamazepine. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Tocainide versus carbamazepine for trigeminal neuralgia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/full#CD004029-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004029-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Proparacaine hydrochloride 0.5% eye drops versus placebo for trigeminal neuralgia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Proparacaine hydrochloride 0.5% eye drops versus placebo for trigeminal neuralgia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> patients with trigeminal neuralgia<br/> <b>Settings:</b> inpatients, the United States<br/> <b>Intervention:</b> proparacaine hydrochloride 0.5% versus placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Proparacaine hydrochloride 0.5% </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Immediate improvement in pain relief</b> </p> <p>Number of participants improved (≥ 2 level decrease in pain on 10‐point verbal rating scale, or pain gone or rare)<br/> <br/> Follow‐up: 30 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>227 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>241 per 1000</b> <br/> (84 to 680) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.06</b> <br/> (0.37 to 2.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>50% pain reduction 12 weeks after the start of treatment</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only trial of this intervention was of short (30 days) duration</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life assessment 12 weeks after the start of treatment</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only trial of this intervention was of short (30 days) duration</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> (not reported) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Two participants in the control group required medication.<br/> <sup>2</sup>This trial had relatively few patients and thus the RR has wide CIs. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Proparacaine hydrochloride 0.5% eye drops versus placebo for trigeminal neuralgia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/full#CD004029-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004029-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Pimozide versus carbamazepine for trigeminal neuralgia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Pimozide versus carbamazepine for trigeminal neuralgia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> patients with trigeminal neuralgia<br/> <b>Settings:</b> outpatients, Venezuela<br/> <b>Intervention:</b> pimozide versus carbamazepine </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Carbamazepine</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Pimozide</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain relief (TN score)</b> </p> <p>Follow‐up: 8 weeks (outcome measured at 6 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean improvement in pain at 6 weeks in the carbamazepine group was<br/> 49.7% </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean improvement in TN score at 6 weeks in the pimozide group was<br/> <b>28.7% greater</b> (20.88% to 36.52% greater) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No definition is given for 'improvement' in this paper and we have not therefore presented the number of participants improved </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>50% pain reduction 12 weeks after the start of treatment</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cross‐over study, each phase 8 weeks</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life assessment 12 weeks after the start of treatment</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cross‐over study, each phase 8 weeks</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> <br/> The number of participants with adverse effects<br/> Follow‐up: 24 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Study report does not provide the number of participants with adverse events for carbamazepine</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>This is a cross‐over study and it may have carry‐over effects. Results are from first period only. Risk of selective reporting bias present: first period TN score available at six weeks, when improvement greatest, but not at end of treatment (eight weeks) (other than in graphical format). Second period TN scores available in graphical format only. Insufficient information to assess selection bias and fully analyse blinding.<br/> <sup>2</sup>No baseline characteristics provided. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Pimozide versus carbamazepine for trigeminal neuralgia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/full#CD004029-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004029-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Tizanidine versus carbamazepine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number improved (reported by participant on global efficacy scale) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.3 [0.05, 1.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Tizanidine versus carbamazepine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/references#CD004029-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004029-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Proparacaine hydrochloride 0.5% versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number improved (reported by participant on verbal pain rating scale) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.37, 2.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Proparacaine hydrochloride 0.5% versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/references#CD004029-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004029-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Pimozide versus carbamazepine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Improvement (reduction in total TN score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>28.70 [20.88, 36.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Pimozide versus carbamazepine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004029.pub4/references#CD004029-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004029.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD004029-note-0001">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004029-note-0009">فارسی</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004029\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004029\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004029\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004029\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004029\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004029\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004029\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004029\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004029\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004029\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004029\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004029\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004029\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004029\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004029\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004029\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004029\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004029\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Oy81c7tH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004029.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004029.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004029.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004029.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004029.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716226415"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004029.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716226423"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004029.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d9a5389571bf6',t:'MTc0MDcxNjIyNi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 